Evidence map›Paper›PMID 41273554›Full record

ArticleAdvances in experimental medicine and biology2026

Clinical Management and Genetic Analysis of a Complex Case of Segmental Infantile Hemangioma with Subcutaneous Pelvic and Gluteal Tumefactions.

Christos Yapijakis, Iphigenia Gintoni, Charikleia Kelaidi, Grigorios Iordanoglou, Vassilios Papadakis, George P Chrousos, Petros Mirilas

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Advances in experimental medicine and biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Christos YapijakisUnit of Orofacial Genetics, First Department of Pediatrics, School of Medicine, National and Kapodistrian University of Athens, "Aghia Sophia" Children's Hospital, Athens, Greece. cyapi@med.uoa.gr.
Iphigenia GintoniUnit of Orofacial Genetics, First Department of Pediatrics, School of Medicine, National and Kapodistrian University of Athens, "Aghia Sophia" Children's Hospital, Athens, Greece.
Charikleia KelaidiDepartment of Pediatric Hematology and Oncology, "Aghia Sophia" Children's Hospital, Athens, Greece.
Grigorios IordanoglouDepartment of Pediatric Surgery, "Aghia Sophia" Children's Hospital, Athens, Greece.
Vassilios PapadakisDepartment of Pediatric Hematology and Oncology, "Aghia Sophia" Children's Hospital, Athens, Greece.
George P ChrousosUniversity Research Institute for the Study of Genetic and Malignant Disorders in Childhood, Choremion Laboratory, "Aghia Sophia" Children's Hospital, Athens, Greece.
Petros MirilasDepartment of Pediatric Surgery, "Aghia Sophia" Children's Hospital, Athens, Greece.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionInfantile hemangiomas (IHs) are the most prevalent noncancerous childhood tumors, affecting up to 10% of infants. IHs develop de novo and following excessive proliferation in the first 4-9 months; they typically degenerate spontaneously in 4-7 years. While treatment is not usually required, 10-15% of cases necessitate clinical or surgical intervention due to functional impairments. Here, we present a complicated capillary IH case, from a clinical and genetic perspective. MATERIAL AND

methodsA 13-month-old patient, with free family history, presented with a cutaneous capillary-venous malformation of the thigh as well as pelvic and gluteal subcutaneous masses, resulting in urinary-bladder displacement, kidney distention, cortical thinning, pyelocaliceal dilation, and rectosigmoid displacement. Following the alleviation of the patient's symptoms and the conduction of a percutaneous nephrostomy, Sirolimus was administered for 2 years at the recommended dose. Moreover, after clinical genetic examination and informed consent of the parents, genomic DNA was extracted from a patient's peripheral blood sample and an analysis of whole-exon sequencing (WES) was performed.

resultsTreatment was successful in diminishing the pelvic and gluteal masses, but the cutaneous malformation remained. WES revealed the heterozygous c.1416A>T:p.Q472H mutation in exon 11 of the KDR gene, that encodes kinase insert domain receptor.

conclusionAccording to the clinical presentation and the results of the genetic analysis, the patient was diagnosed with segmental capillary IH, caused by a missense pathogenic variant in the KDR gene, which impairs protein function and might also be responsible for the presented subcutaneous malformations.

Indexed as

HemangiomaSkin NeoplasmsButtocksChild, PreschoolHumansInfantPelvisComplicationsGenetic diagnosisGeneticsInfantile hemangiomaKDRLUMBAR syndromeLumbosacral hemangiomaSegmental hemangiomaSirolimusTreatmentVEGFR2WES

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.